Alterity Therapeutics Limited ATH.AX Stock
Alterity Therapeutics Limited Price Chart
Alterity Therapeutics Limited ATH.AX Financial and Trading Overview
| Alterity Therapeutics Limited stock price | 0.0070 AUD |
| Previous Close | 0.006 AUD |
| Open | 0.007 AUD |
| Bid | 0.006 AUD x 0 |
| Ask | 0.007 AUD x 0 |
| Day's Range | 0.006 - 0.007 AUD |
| 52 Week Range | 0.006 - 0.02 AUD |
| Volume | 461.65K AUD |
| Avg. Volume | 1.35M AUD |
| Market Cap | 14.5M AUD |
| Beta (5Y Monthly) | 0.885823 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 AUD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
ATH.AX Valuation Measures
| Enterprise Value | -10750013 AUD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2.8151555 |
| Price/Book (mrq) | 0.5 |
| Enterprise Value/Revenue | -2.087 |
| Enterprise Value/EBITDA | 0.669 |
Trading Information
Alterity Therapeutics Limited Stock Price History
| Beta (5Y Monthly) | 0.885823 |
| 52-Week Change | -62.50% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.02 AUD |
| 52 Week Low | 0.006 AUD |
| 50-Day Moving Average | 0.0072 AUD |
| 200-Day Moving Average | 0.0098925 AUD |
ATH.AX Share Statistics
| Avg. Volume (3 month) | 1.35M AUD |
| Avg. Daily Volume (10-Days) | 807.09K AUD |
| Shares Outstanding | 2.42B |
| Float | 2.09B |
| Short Ratio | N/A |
| % Held by Insiders | 15.00% |
| % Held by Institutions | 0.32% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | -277.57% |
| Operating Margin (ttm) | -312.37% |
| Gross Margin | 93.81% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -25.67% |
| Return on Equity (ttm) | -41.29% |
Income Statement
| Revenue (ttm) | 5.15M AUD |
| Revenue Per Share (ttm) | 0.002 AUD |
| Quarterly Revenue Growth (yoy) | 1.09% |
| Gross Profit (ttm) | 4.76M AUD |
| EBITDA | -16056910 AUD |
| Net Income Avi to Common (ttm) | -14295439 AUD |
| Diluted EPS (ttm) | -0.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 25.34M AUD |
| Total Cash Per Share (mrq) | 0.01 AUD |
| Total Debt (mrq) | 89.72K AUD |
| Total Debt/Equity (mrq) | 0.32 AUD |
| Current Ratio (mrq) | 6.347 |
| Book Value Per Share (mrq) | 0.012 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -13589841 AUD |
| Levered Free Cash Flow (ttm) | -7400959 AUD |
Profile of Alterity Therapeutics Limited
| Country | Australia |
| State | VIC |
| City | Melbourne |
| Address | 460 Bourke Street |
| ZIP | 3000 |
| Phone | 61 3 9349 4906 |
| Website | https://alteritytherapeutics.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 12 |
Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidate is ATH434 that has completed Phase I clinical trial for the treatment of Parkinson's disease. It is also developing PBT2 that has completed Phase 2a clinical trial to treat Alzheimer's disease. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. Alterity Therapeutics Limited was incorporated in 1997 and is headquartered in Melbourne, Australia.
Q&A For Alterity Therapeutics Limited Stock
What is a current ATH.AX stock price?
Alterity Therapeutics Limited ATH.AX stock price today per share is 0.0070 AUD.
How to purchase Alterity Therapeutics Limited stock?
You can buy ATH.AX shares on the ASX exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Alterity Therapeutics Limited?
The stock symbol or ticker of Alterity Therapeutics Limited is ATH.AX.
Which industry does the Alterity Therapeutics Limited company belong to?
The Alterity Therapeutics Limited industry is Biotechnology.
How many shares does Alterity Therapeutics Limited have in circulation?
The max supply of Alterity Therapeutics Limited shares is 5.24B.
What is Alterity Therapeutics Limited Price to Earnings Ratio (PE Ratio)?
Alterity Therapeutics Limited PE Ratio is now.
What was Alterity Therapeutics Limited earnings per share over the trailing 12 months (TTM)?
Alterity Therapeutics Limited EPS is 0 AUD over the trailing 12 months.
Which sector does the Alterity Therapeutics Limited company belong to?
The Alterity Therapeutics Limited sector is Healthcare.